Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1709

1.

Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(12):1264-75.

PMID:
23264245
[PubMed - indexed for MEDLINE]
Free Article
2.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

PMID:
23180517
[PubMed - indexed for MEDLINE]
Free Article
3.

Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.

PMID:
23074465
[PubMed]
Free PMC Article
4.

Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.

Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.

Pacing Clin Electrophysiol. 2010 Jun 1;33(6):696-704. doi: 10.1111/j.1540-8159.2009.02669.x. Epub 2010 Jan 5.

PMID:
20059719
[PubMed - indexed for MEDLINE]
5.

[Antitachyarrhythmic interventions of implantable cardioverter-defibrillator in primary and secondary sudden cardiac death prevention patients].

Piekarz J, Rydlewska A, Majewski J, Lelakowski J.

Pol Merkur Lekarski. 2012 Jun;32(192):368-73. Polish.

PMID:
22891561
[PubMed - indexed for MEDLINE]
6.

Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.

Streitner F, Kuschyk J, Dietrich C, Mahl E, Streitner I, Doesch C, Veltmann C, Schimpf R, Wolpert C, Borggrefe M.

Clin Cardiol. 2011 Oct;34(10):604-9. doi: 10.1002/clc.20949. Epub 2011 Sep 1.

PMID:
21887690
[PubMed - indexed for MEDLINE]
7.

Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.

Gatzoulis KA, Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, Gialernios T, Arsenos P, Karystinos G, Sideris S, Kallikazaros I, Stefanadis C.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):504-12. doi: 10.1161/CIRCEP.113.000216. Epub 2013 Apr 15.

PMID:
23588627
[PubMed - indexed for MEDLINE]
Free Article
8.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

PMID:
19506335
[PubMed - indexed for MEDLINE]
Free Article
9.

[Influence of increased mean heart rate at rest on mortality and ventricular tachycardia resulting in adequate intervention in patients after implantable cardioverter-defibrillator implantation].

Lelakowski J, Rydlewska A, Majewski J, Bednarek J, Zabek A, Małecka B, Pudło J.

Przegl Lek. 2012;69(11):1194-8. Polish.

PMID:
23646446
[PubMed - indexed for MEDLINE]
10.

Impact of left ventricular ejection fraction on occurrence of ventricular events in defibrillator patients with coronary artery disease.

Schaer B, Sticherling C, Szili-Torok T, Osswald S, Jordaens L, Theuns DA.

Europace. 2011 Nov;13(11):1562-7. doi: 10.1093/europace/eur169. Epub 2011 Jun 28.

PMID:
21712284
[PubMed - indexed for MEDLINE]
Free Article
11.

Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.

Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.

Europace. 2006 Aug;8(8):618-24.

PMID:
16864615
[PubMed - indexed for MEDLINE]
Free Article
12.

Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death [Internet].

Uhlig K, Balk EM, Earley A, Persson R, Garlitski AC, Chen M, Lamont JL, Miligkos M, Avendano EE.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun 26.

PMID:
25356453
[PubMed]
Books & Documents
13.

Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.

Kreuz J, Horlbeck F, Schrickel J, Linhart M, Fimmers R, Mellert F, Nickenig G, Schwab JO.

Clin Cardiol. 2012 Sep;35(9):575-9. doi: 10.1002/clc.22018. Epub 2012 Jun 15.

PMID:
22707222
[PubMed - indexed for MEDLINE]
14.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
[PubMed - indexed for MEDLINE]
15.

Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up.

Karaoguz R, Maydanozcu S, Altun T, Güldal M, Akyürek O, Erol C.

Int Heart J. 2006 Sep;47(5):763-73.

PMID:
17106147
[PubMed - indexed for MEDLINE]
Free Article
16.

Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.

Silka MJ, Kron J, Dunnigan A, Dick M 2nd.

Circulation. 1993 Mar;87(3):800-7.

PMID:
8443901
[PubMed - indexed for MEDLINE]
17.

The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.

Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G.

Europace. 2004 Sep;6(5):400-6. Erratum in: Europace. 2005 Jan;7(1):91.

PMID:
15294264
[PubMed - indexed for MEDLINE]
Free Article
18.

Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy.

Verma A, Sarak B, Kaplan AJ, Oosthuizen R, Beardsall M, Wulffhart Z, Higenbottam J, Khaykin Y.

Pacing Clin Electrophysiol. 2010 Mar;33(3):320-9. doi: 10.1111/j.1540-8159.2009.02566.x. Epub 2009 Oct 1.

PMID:
19796352
[PubMed - indexed for MEDLINE]
19.

[14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].

Vester EG, Dees H, Dobran I, Hennersdorf M, Perings C, Heydthausen M, Winter J, Strauer BE.

Z Kardiol. 2000;89 Suppl 3:194-205. German.

PMID:
10810803
[PubMed - indexed for MEDLINE]
20.

Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.

Martinelli M, de Siqueira SF, Sternick EB, Rassi A Jr, Costa R, Ramires JA, Kalil Filho R.

Am J Cardiol. 2012 Oct 1;110(7):1040-5. doi: 10.1016/j.amjcard.2012.05.040. Epub 2012 Jun 20.

PMID:
22727179
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk